Article Data

  • Views 1893
  • Dowloads 110

Case Reports

Open Access

Obturator mononeuropathy due to adenocarcinoma of unknown primary origin

  • R. Türkoğlu1
  • M. Gencer1
  • F.V. Aker2
  • K. Meriç3
  • S.Y. Gökçeer1
  • A. Çoban4
  • E. Tüzün4,*,

1Department of Neurology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey

2Department of Pathology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey

3Department of Radiology, Haydarpasa Numune Education and Research Hospital, Istanbul, Turkey

4Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

DOI: 10.12892/ejgo3253.2016 Vol.37,Issue 6,December 2016 pp.882-883

Published: 10 December 2016

*Corresponding Author(s): E. Tüzün E-mail: drerdem@yahoo.com

Abstract

A 35-year-old woman presented with a three-month history of left groin and thigh pain. Neurological examination and electromyography showed pathological features consistent with obturator nerve involvement. Imaging studies revealed a left retroperitoneal mass, which by pathological examination was shown to be metastatic adenocarcinoma of possible Mullerian origin. Primary tumor could not be detected in a follow-up period of three years. Obturator mononeuropathy can be the first manifestation of cancer. Cancer of unknown primary origin may occasionally be local, well-restricted and carry a good prognosis.

Keywords

Obturator nerve; Mononeuropathy; Groin pain; Tumor; Adenocarcinoma.

Cite and Share

R. Türkoğlu,M. Gencer,F.V. Aker,K. Meriç,S.Y. Gökçeer,A. Çoban,E. Tüzün. Obturator mononeuropathy due to adenocarcinoma of unknown primary origin. European Journal of Gynaecological Oncology. 2016. 37(6);882-883.

References

[1] Rogers L.R., Borkowski G.P., Albers J.W., Levin K.H., Barohn R.J., Mitsumoto H.: “Obturator mononeuropathy caused by pelvic cancer: six cases”. Neurology, 1993, 43, 1489.

[2] Sorenson E.J., Chen J.J., Daube J.R.: “Obturator neuropathy: causes and outcome”. Muscle Nerve, 2002, 25, 605.

[3] Tipton J.S.: “Obturator neuropathy”. Curr. Rev. Musculoskelet. Med., 2008, 1, 234.

[4] Pavlidis N., Pentheroudakis G.: “Cancer of unknown primary site”. Lancet, 2012, 379, 1428.

[5] Varadhachary G.R., Raber M.N.: “Cancer of unknown primary site”. N. Engl. J. Med., 2014, 371, 757.

[6] Laury A.R., Perets R., Piao H., Krane J.F., Barletta J.A., French C. et al.: “A comprehensive analysis of PAX8 expression in human epithelial tumors”. Am. J. Surg. Pathol., 2011, 35, 816.

[7] Perlino E., Maenza S., Marra E., Ciampolillo A., Marra G., Derobertis O., et al.: “Ttf1 gene-expression in human proliferating thyroid- diseases”. Oncol. Rep., 1994, 1, 1097.

[8] Li G., Passebosc-Faure K., Lambert C., Gentil-Perret A., Blanc F., Oosterwijk E., et al.: “Flow cytometric analysis of antigen expression in malignant and normal renal cells”. Anticancer Res., 2000, 20, 2773.

Submission Turnaround Time

Top